PeptidePedia The community reference

Information for Survodutide

Page information·measured at build time

Technical and provenance information about Survodutide. All figures on this page are measured from the emitted page rather than declared.

Basic information

Display titleSurvodutide
Default sort keySurvodutide
NamespaceArticle (main)
Page kindCompound
Page length (source, bytes)5,445
Rendered word count644
Internal wiki links on the page20
Defined citations4
Top-level sections3
Subsections0
Tables0
Figures0
InfoboxYes — compound
Maintenance bannersmedical
Indexing by robotsAllowed

Edit history

Page creatorIncretinIvo
Date of page creation6 November 2024
Latest editorCustomsClarke
Date of latest edit17 July 2026
Total number of edits28
Total number of distinct authors26
Minor edits9
Automated (bot) edits3
Recent number of edits (last 90 days)3
Talk page posts6

Principal authors

EditorEditsShareDeclared focus
IcodecIndra310.7%GLP-1 receptor agonists and related compounds
IncretinIvo13.6%incretin biology and receptor pharmacology
NauseaNoor13.6%adverse effects and clinical safety
MolarMassMaeve13.6%GLP-1 receptor agonists and related compounds
NeutralNikolai13.6%policy, notability and deletion
Chromatokid13.6%analytical chemistry and chromatography
FmocFrancis13.6%peptide synthesis and supply chain
ArchiveBot13.6%policy, notability and deletion
AmylinAmos13.6%incretin biology and receptor pharmacology
SemaglutideSasha13.6%GLP-1 receptor agonists and related compounds
TSH_Tallulah13.6%laboratory medicine and biomarkers
TirzTaxonomist13.6%GLP-1 receptor agonists and related compounds

Category membership